Literature DB >> 11867117

Risk of early febrile seizure with perinatal exposure to nucleoside analogues.

A Landreau-Mascaro, B Barret, M J Mayaux, M Tardieu, S Blanche.   

Abstract

The frequency of seizures was studied in a prospective cohort of French children born to HIV-1-infected mothers. The analysis was restricted to the 4426 uninfected children, whether or not exposed to antiretrovirals. 81 convulsions were reported up to the age of 18 months, and 30 children fulfilled the criteria for simple febrile seizures. The risk of first febrile seizure was higher for children perinatally exposed to antiretrovirals than for those not exposed (log-rank test: p=0.0198). A similar trend was noted for other non-neonatal seizures (p=0.0537) but not for neonatal seizures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867117     DOI: 10.1016/S0140-6736(02)07717-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

Review 1.  Treating HIV during pregnancy: an update on safety issues.

Authors:  D Heather Watts
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants.

Authors:  George K Siberry; Paige L Williams; Hermann Mendez; George R Seage; Denise L Jacobson; Rohan Hazra; Kenneth C Rich; Raymond Griner; Katherine Tassiopoulos; Deborah Kacanek; Lynne M Mofenson; Tracie Miller; Linda A DiMeglio; D Heather Watts
Journal:  AIDS       Date:  2012-06-01       Impact factor: 4.177

3.  Global HIV neurology: a comprehensive review.

Authors:  Kiran T Thakur; Alexandra Boubour; Deanna Saylor; Mitashee Das; David R Bearden; Gretchen L Birbeck
Journal:  AIDS       Date:  2019-02-01       Impact factor: 4.177

4.  Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean.

Authors:  Alicen B Spaulding; Qilu Yu; Lucy Civitello; Marisa M Mussi-Pinhata; Jorge Pinto; Ivete M Gomes; Jorge O Alarcón; George K Siberry; D Robert Harris; Rohan Hazra
Journal:  AIDS Res Hum Retroviruses       Date:  2016-04       Impact factor: 2.205

5.  Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected.

Authors:  Claudia S Crowell; Paige L Williams; Cenk Yildirim; Russell B Van Dyke; Renee Smith; Ellen G Chadwick; George R Seage; Alexandria Diperna; Rohan Hazra
Journal:  AIDS       Date:  2020-07-15       Impact factor: 4.177

6.  Maternal HIV/AIDS status and neurological outcomes in neonates: a population-based study.

Authors:  Hamisu M Salihu; Euna M August; Muktar Aliyu; Kara M Stanley; Hanna Weldeselasse; Alfred K Mbah
Journal:  Matern Child Health J       Date:  2012-04

Review 7.  Neurological and psychiatric adverse effects of antiretroviral drugs.

Authors:  Michael S Abers; Wayne X Shandera; Joseph S Kass
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

8.  Evaluation and treatment of the human immunodeficiency virus-1-exposed infant.

Authors: 
Journal:  Paediatr Child Health       Date:  2004-07       Impact factor: 2.253

9.  Infant growth outcomes after maternal tenofovir disoproxil fumarate use during pregnancy.

Authors:  Carla E Ransom; Yanling Huo; Kunjal Patel; Gwendolyn B Scott; Heather D Watts; Paige Williams; George K Siberry; Elizabeth G Livingston
Journal:  J Acquir Immune Defic Syndr       Date:  2013-12-01       Impact factor: 3.731

Review 10.  Mitochondrial disorders among infants exposed to HIV and antiretroviral therapy.

Authors:  Michele Jonsson Funk; Suzanne E Belinson; Jeanne M Pimenta; Megan Morsheimer; David C Gibbons
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.